Englisch Dr. Stanley Fahn, H. Houston Merritt Professor of Neurology and Director of the Center for Parkinson’s Disease and Other Movement Disorders at Columbia University in New York City.
Dr. Fahn is the Scientific Director of the (American) Parkinson’s Disease Foundation and Past President of the American Academy of Neurology (AAN). He is founder of the Movement Disorder Society and co founded the Parkinson Study Group (PSG), a consortium of clinical investigators dedicated to conducting controlled clinical trials on the prevention and treatment of PD.
Dr Fahn continues to be active in patient care, research, and teaching and has trained over 120 movement disorder fellows, including many who are professors of neurology around the globe. Dr. Fahn is the recipient of numerous honours and awards for outstanding clinical research. Among his many accomplishments are his organization and execution of the development of the Unified Parkinson’s Disease Rating Scale (UPDRS) to determine the severity of Parkinson’s disease, and the modification and popularization of the use of the Schwab England ADL which measures quality of life.
He served as chair and organizer of the first World Parkinson Congress held in Washington, DC, in 2006, co-organized the second World Parkinson Congress, held in Glasgow, Scotland, in 2010 and co-chaired the third World Parkinson Congress in Montreal, Canada, in 2013.
His clinical research consists of co-authoring 135 peer reviewed articles and participating in 3 clinical trials in the past 15 years. In particular, he has co-authored 107 articles and participated in 3 clinical trials in the study of Parkinson’s Disease.
